Spots Global Cancer Trial Database for Evaluation of Screening Methods for Treatment of Meibomian Gland Dysfunction
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Evaluation of Screening Methods for Treatment of Meibomian Gland Dysfunction
Official Title: Pilot Study for Evaluation of LipiFlow Screening Methods
Study ID: NCT01202747
Interventions
Study Description
Brief Summary: The objective is to evaluate the feasibility of using additional screening methods to optimize effectiveness outcomes with the LipiFlow System for application of heat and pressure therapy in adult patients with chronic cystic conditions of the eyelids, including meibomian gland dysfunction, also known as evaporative dry eye or lipid deficiency dry eye, and chalazia. The screening methods include diagnostic expression of the meibomian glands and interferometry assessment of the tear film.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
, Hoffman Estates, Illinois, United States
, Boston, Massachusetts, United States
, Winchester, Massachusetts, United States
Contact Details
Name: Christy Stevens, OD
Affiliation: TearScience
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
